首页> 外文期刊>Genetics and molecular biology: publication of the Sociedade Brasileira de Genetica >Association of T174M polymorphism of angiotensinogen gene with essential hypertension: a meta-analysis
【24h】

Association of T174M polymorphism of angiotensinogen gene with essential hypertension: a meta-analysis

机译:血管紧张素原基因T174M多态性与原发性高血压的关联:一项荟萃分析

获取原文
           

摘要

The association between T174M polymorphism of angiotensinogen gene and essential hypertension risk remains controversial. We herein performed a meta-analysis to achieve a reliable estimation of their relationship. All the studies published up to May 2013 on the association between T174M polymorphism and essential hypertension risk were identified by searching the electronic repositories PubMed, MEDLINE and EMBASE, Springer, Elsevier Science Direct, Cochrane Library and Google Scholar. Data were extracted and pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated. Ultimately, nine eligible studies, including 2188 essential hypertension cases and 2459 controls, were enrolled in this meta-analysis. No significant associations were found under the overall ORs for M-allele comparison (M vs. T, pooled OR 0.92, 95% CI 0.62-1.37), MM vs. TT (pooled OR 0.86, 95% CI 0.29-2.51), TM vs. TT n (pooled OR 0.91, 95% CI 0.63-1.32), recessive model (MM vs. TT+TM, pooled OR 0.89, 95% CI 0.35-2.30), dominant model (MM+TM vs. TT, pooled OR 0.91, 95% CI 0.60-1.38) between T174M polymorphism and risk for essential hypertension. This meta-analysis suggested that the T174M polymorphism of the angiotensinogen gene might not be associated with the susceptibility of essential hypertension in Asian or European populations.
机译:血管紧张素原基因的T174M多态性与原发性高血压风险之间的关联仍存在争议。我们在这里进行了荟萃分析,以实现对其关系的可靠估计。通过搜索电子存储库PubMed,MEDLINE和EMBASE,Springer,Elsevier Science Direct,Cochrane Library和Google Scholar,确定了截至2013年5月发表的有关T174M多态性与高血压风险之间关系的所有研究。提取数据并计算具有95%置信区间(95%CI)的合并比值比(OR)。最终,这项荟萃分析纳入了9项合格研究,包括2188例原发性高血压病例和2459例对照。在M等位基因比较的总OR下未发现显着相关性(M vs.T,合并OR 0.92,95%CI 0.62-1.37),MM vs.TT(合并OR 0.86,95%CI 0.29-2.51),TM vs.TT n(合并OR 0.91,95%CI 0.63-1.32),隐性模型(MM vs.TT + TM,合并OR 0.89,95%CI 0.35-2.30),优势模型(MM + TM vs.TT,综合T174M基因多态性与原发性高血压风险之间的比率为0.91,95%CI为0.60-1.38)。这项荟萃分析表明,血管紧张素原基因的T174M多态性可能与亚洲或欧洲人群中原发性高血压的易感性无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号